Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors. 2015

Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
Department of Pathology, Queen Elizabeth II Health Sciences Center, Capital District Health Authority, Halifax, NS, B3H 1V8, Canada.

Merkel cell polyomavirus is of oncogenic significance in approximately 80% of Merkel cell carcinomas. Morphological subcategories of the tumor differ in regard to viral status, the rare combined type being uniformly virus negative and the predominant pure type being mainly virus positive. Indications that different biological subsets of the tumor exist led us to explore this diversity. In an Eastern Canadian cohort of cases (75 patients; mean age, 76 years [range, 43-91]; male/female ratio, 43:32; 51 [68%] pure and 24 [34%] combined tumors), we semiquantitatively compared the immunohistochemical expression of 3 cellular proteins (p53, Bcl-2, and c-kit) in pure versus combined groups. Viral status was known in a subset of cases. The significant overexpression of p53 in the combined group (mean [SD], 153.8 [117.8] versus 121.6 [77.9]; P = .01) and the increased epidermal expression of this protein (p53 patches) in the same group lend credence to a primary etiologic role for sun damage in these cases. Expression of Bcl-2 and c-kit did not differ significantly between the 2 morphological groups. A relative increase in c-kit expression was significantly associated with a virus-negative status (median [interquartile range], 100 [60-115] versus 70 [0-100]; P = .03). Emerging data reveal divergent biological pathways in Merkel cell carcinoma, each with a characteristic immunohistochemical profile. Virus-positive tumors (all pure) exhibit high retinoblastoma protein and low p53 expression, whereas virus-negative cases (few pure and all combined) show high p53 and relatively high c-kit expression. The potential biological implications of this dichotomy call for consistent stratification of these tumors in future studies.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009674 Nova Scotia A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND AND LABRADOR. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. (From Webster's New Geographical Dictionary, 1988, p871 & Room, Brewer's Dictionary of Names, 1992, p384)
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
June 1996, The American Journal of dermatopathology,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
May 2015, The Journal of dermatology,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
April 1996, Journal of cutaneous pathology,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
September 2009, The American journal of surgical pathology,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
January 2003, Cell death and differentiation,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
January 1999, Anticancer research,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
May 1998, Scandinavian journal of gastroenterology,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
October 1999, The Journal of urology,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
January 1996, Anticancer research,
Jonathan H Lai, and Kirsten E Fleming, and Thai Yen Ly, and Sylvia Pasternak, and Marek Godlewski, and Steve Doucette, and Noreen M Walsh
September 2002, Transplantation proceedings,
Copied contents to your clipboard!